Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis

Yong-Wan KimW K Alfred Yung


The Cancer Genome Atlas (TCGA) project is a large-scale effort with the goal of identifying novel molecular aberrations in glioblastoma (GBM). Here, we describe an in-depth analysis of gene expression data and copy number aberration (CNA) data to classify GBMs into prognostic groups to determine correlates of subtypes that may be biologically significant. To identify predictive survival models, we searched TCGA in 173 patients and identified 42 probe sets (P = .0005) that could be used to divide the tumor samples into 3 groups and showed a significantly (P = .0006) improved overall survival. Kaplan-Meier plots showed that the median survival of group 3 was markedly longer (127 weeks) than that of groups 1 and 2 (47 and 52 weeks, respectively). We then validated the 42 probe sets to stratify the patients according to survival in other public GBM gene expression datasets (eg, GSE4290 dataset). An overall analysis of the gene expression and copy number aberration using a multivariate Cox regression model showed that the 42 probe sets had a significant (P < .018) prognostic value independent of other variables. By integrating multidimensional genomic data from TCGA, we identified a specific survival model in a new prognostic group ...Continue Reading


Mar 19, 2014·Oncogenesis·A BalbousL Karayan-Tapon
Aug 27, 2014·Pathology Oncology Research : POR·Katalin Eder, Bernadette Kalman
Aug 8, 2014·Surgical Neurology International·Taylor A Wilson
Mar 26, 2014·Neuro-oncology·Naamit K GerberTimothy A Chan
Aug 21, 2014·Surgical Neurology International·Gustavo MendezDonald A Ross
Dec 6, 2014·Neuroimaging Clinics of North America·Ilana Zalcberg Renault, Denise Golgher
Dec 30, 2014·T︠S︡itologii︠a︡ i genetika·V V DmitrenkoV M Kavsan
Mar 17, 2016·Biostatistics·Ruoqing ZhuShuangge Ma
Mar 13, 2014·International Journal of Cancer. Journal International Du Cancer·Guido ReifenbergerGerman Glioma Network
Mar 1, 2015·Journal of Neuro-oncology·Jennifer S SimsJeffrey N Bruce
Oct 27, 2016·The British Journal of Radiology·Ahmad ChaddadCamel Tanougast
Aug 10, 2018·Future Medicinal Chemistry·Jaclyn J RenfrowRoy E Strowd
Jan 11, 2019·Cancers·Kelvin K WongStephen T C Wong
Jan 8, 2020·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Hongchao PanMelitta Schachner
Sep 24, 2020·Journal of Cellular Physiology·Huaijun ChenGao Chen
May 7, 2015·Journal of Neuro-oncology·Shilpa S PatilPaturu Kondaiah
May 10, 2018·Journal of Neuropathology and Experimental Neurology·Timothy E RichardsonKimmo J Hatanpaa
Jan 30, 2020·BMC Cancer·Chitrangda SrivastavaKunzang Chosdol
Jun 4, 2020·Medical & Biological Engineering & Computing·Navodini WijethilakeHongliang Ren
Dec 3, 2017·Journal of Neuro-oncology·Eric GoetheNaveen Pemmaraju
Oct 12, 2018·Scientific Reports·Jing TangYang Zhang
Jun 14, 2017·Human Genetics·Fabiana Marcelino MelisoLuiz O Penalva
Mar 4, 2020·Medical & Biological Engineering & Computing·Amin Zadeh ShiraziGuillermo A Gomez


Feb 15, 2001·Nature Genetics·A Di CristofanoP P Pandolfi
Nov 10, 2001·Cytogenetics and Cell Genetics·S LoeperS Urbschat
May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Rebecca A BetenskyJ Gregory Cairncross
Aug 7, 2002·Journal of Computational Biology : a Journal of Computational Molecular Cell Biology·Michael D RadmacherRichard M Simon
May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnab ChakravartiJay S Loeffler
Oct 12, 2004·Biostatistics·Adam B OlshenMichael Wigler
Jun 17, 2005·Cancer Research·Mieko E FukudaNaohiko Seki
Aug 27, 2005·The New England Journal of Medicine·Nader SanaiMitchel Berger
Sep 17, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kristin K ZornMichael J Birrer
Sep 20, 2005·Cancer Cell·Susan E MoodyLewis A Chodosh
Nov 3, 2005·Journal of the National Cancer Institute·Marta M AlonsoCandelaria Gomez-Manzano
Sep 13, 2006·Molecular Cancer Research : MCR·Cho-Lea TsoStanley F Nelson
Sep 6, 2007·Brain : a Journal of Neurology·Dietmar KrexGerman Glioma Network
Dec 7, 2007·The Journal of Clinical Investigation·Michael T DebiesEdward J Gunther
Apr 12, 2008·Trends in Molecular Medicine·Ryuya Yamanaka
Feb 27, 2009·Cancer Research·Aiguo LiHoward A Fine
Mar 6, 2009·Genes & Development·Anna M Puzio-KuterCory Abate-Shen
Mar 6, 2009·Nature Reviews. Cancer·Kornelia Polyak, Robert A Weinberg
Jul 7, 2009·Nature Genetics·Sanjay SheteRichard S Houlston
Dec 25, 2009·Nature·Maria Stella CarroAntonio Iavarone
Feb 13, 2010·Neuro-oncology·Howard ColmanKen Aldape
Apr 20, 2010·Cancer Cell·Houtan NoushmehrCancer Genome Atlas Research Network
Nov 17, 2010·Toxicologic Pathology·Terreia S Jones, Eric C Holland
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Xiaowei YanQiang Tian
Jul 6, 2011·Nature Reviews. Neurology·Gregory Riddick, Howard A Fine

Related Concepts

Glioblastoma Multiforme
Gene Expression Regulation, Neoplastic
DNA Copy Number Changes
Tumor Markers
Gene Expression
Epithelial to Mesenchymal Transition
Nested Case-Control Studies

Related Feeds

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.

Cancer Genomics

Cancer genomics employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research here.